This is a $1,124.88 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of 30 mg/mL ketorolac vials. The contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This award does not have a set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,328.50, is for the supply of 4567132196 - KETOROLAC 60 MG/2 ML VIAL 2ML, a prescription medication. The contract is a Firm Fixed Price Delivery Order, with a period of performance through February 4, 2025. The contract was not awarded with any set-aside designation, indicating open...
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,502,885 units of Ketorolac 60 mg/2 ml vials. The total ceiling value of the contract is $1,591.70 with a completion date of June 11, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp also holds a significant...
This federal contract award, with a value of $1,348.63, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4566708420 KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is December 13, 2024. This award is a child contract under a larger Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ketorolac 30 mg/mL vials. The contract has a ceiling value of $7,414.75 and a period of performance through August 23, 2024. It is a firm fixed-price contract for the delivery of this pharmaceutical product. The contract does not utilize a small business set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ketorolac 60 mg/2 ml vial (2 ml). The contract, which does not have a set-aside designation, is a Delivery Order with a Firm Fixed Price of $1,164.06 and a completion date of June 16, 2025. The contract is funded by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen Drug Corp is the prime contractor and there are no noted subcontractors. This contract is...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Ketorolac 30mg/ml in quantities of 25 doses. The award, valued at $15,949.23, was made by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of December 6, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,488.40 firm fixed-price delivery order is for the supply of 4566728770 - Ketorolac 30 mg/ml vial, a pain management medication. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ketorolac 30 mg/ml vials. The contract has a ceiling value of $16,221.75 and a period of performance through December 22, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The order is for the supply of 4563889817 KETOROLAC 60 MG/2 ML VIAL 2ML, a pharmaceutical product, with a potential value of $1,647.30 and a completion date of March 8, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor under this...